3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
152
Lymphoma, Mantle-Cell
30
Lymphoma, Non-Hodgkin
22
Lymphoma, Follicular
22
Lymphoma
22
Recurrence
21
Neoplasms, Plasma Cell
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia, Myeloid, Acute
12
Waldenstrom Macroglobulinemia
11
Lymphoma, Large B-Cell, Diffuse
11
Immunoglobulin Light-chain Amyloidosis
10
Neoplasms
8
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma, B-Cell
7
Leukemia
6
Carcinoma, Non-Small-Cell Lung
6
Myelodysplastic Syndromes
5
Hematologic Neoplasms
5
Brain Neoplasms
5
Amyloidosis
5
Lymphoma, Large-Cell, Immunoblastic
4
Hematologic Diseases
4
Congenital Abnormalities
4
Prostatic Neoplasms
3
Paraproteinemias
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Monocytic, Acute
3
Leukemia, Erythroblastic, Acute
3
Interventions
tislelizumab
4
talazoparib
4
pembrolizumab
4
Docetaxel
4
Nivolumab
3
PM 01183
2
MLN 8237
2
Itraconazole
2
Fluorouracil
2
Cisplatin
2
Carboplatin
2
zimberelimab
1
utomilumab
1
urelumab
1
ulixertinib
1
trifluridine tipiracil drug combination
1
sitravatinib
1
sapanisertib
1
pexidartinib
1
pevonedistat
1
peposertib
1
niraparib
1
mogamulizumab
1
lenvatinib
1
ixabepilone
1
eribulin
1
durvalumab
1
dalotuzumab
1
avelumab
1
ascrinvacumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Solid Tumors
×
Bortezomib
×
Clear all
No trials found.